- Isis Pharma held a rescheduled conference call on 9/12/11 with a guest expert Dr. John Kastelein who recently presented long-term safety and efficacy data for mipomersen (Kynamro) at a scientific conference.
- Find detailed company and pipeline info on ISIS research page.
- See more biotech webcasts and links to my notes on Upcoming Events page.
- Click here to download PDF of the slide deck from the talk
- Follow this link to view my complete notes and analysis from this presentation, including some of the figures from the talk, as well as the extensive question and answer session.
RSS Feed
